Trends in injection drug use behaviors over 10 years among street youth

Drug and Alcohol Dependence

Volumn 89, Issue 2-3, 2007, Pages 170-175

  Roy, Élise ^a,b,c   Boudreau, Jean François ^a   Leclerc, Pascale ^b   Boivin, Jean François ^b,c   Godin, Gaston ^d  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b Gouvernement du Quebec   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

Author keywords

Cohort studies; Homeless youth; intravenous; Needle sharing; Substance abuse; Trends

Indexed keywords

STREET DRUG;

ADULT; ARTICLE; BEHAVIOR; CANADA; CONTROLLED STUDY; DATA ANALYSIS; DRUG USE; FEMALE; FOLLOW UP; HOMELESSNESS; HUMAN; INCIDENCE; JUVENILE; MALE; PRIORITY JOURNAL; QUESTIONNAIRE;

ADOLESCENT; ADULT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HEALTH SERVICES NEEDS AND DEMAND; HOMELESS YOUTH; HUMANS; INCIDENCE; MALE; NEEDLE SHARING; ODDS RATIO; PROSPECTIVE STUDIES; QUEBEC; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34248583546     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2006.12.025     Document Type: Article

References (59)

1. Armitage P., and Berry G. Statistical Methods in Medical Research. 3rd ed. (1994), Blackwell Science Ltd., Cambridge
2. Beardsley M., Deren S., Tortu S., Goldstein M.F., Ziek K., and Hamid R. Trends in injection risk behaviors in a sample of New York City injection drug users: 1992-1995. J. Acquir. Immune Defic. Syndr. 20 (1999) 283-289
3. Bell M., and Gray R. Preventing initiation to injection drug use through programs targeting IDUs-PSI' break the cycle program in Central Asia. Presented at the 17th International Conference on the Reduction of Drug Related Harm. Vancouver, Canada, April 30-May 4 (2006) 103 abstract no. Tu.07.4
4. Booth R.E., Kwiatkowski C.F., Mikulich-Gilbertson S.K., Brewster J.T., Salomonsen-Sautel S., Corsi K.F., and Sinitsyna L. Predictors of risky needle use following interventions with injection drug users in Ukraine. Drug Alcohol Depend. 82 Suppl. 1 (2006) S49-S55
5. Bukstein O.G. Adolescent Substance Abuse: Assessment, Prevention, and Treatment (1995), John Wiley & Sons, Inc., New York, NY
6. Centers for Disease Control and Prevention (CDCP). Trends in injection drug use among persons entering addiction treatment-New Jersey, 1992-1999. Morb. Mortal. Wkly. Rep. 50 (2001) 378-381
7. Clatts M.C., Davis W.R., Sotheran J.L., and Atillasoy A. Correlates and distribution of HIV risk behaviors among homeless youths in New York City: implications for prevention and policy. Child Welfare 77 (1998) 195-207
8. Clayton D., and Schifflers E. Models for temporal variation in cancer rates. I. Age-period and age-cohort models. Stat. Med. 6 (1987) 449-467
9. Crofts N., and Aitken C.K. Incidence of bloodborne virus infection and risk behaviors in a cohort of injecting drug users in Victoria, 1990-1995. Can. Med. Assoc. J. 167 (1997) 17-20
10. DeMatteo D., Major C., Block B., Coates R., Fearon M., Goldberg E., King S.M., Millson M., O'Shaughnessy M., and Read S.E. Toronto street youth and HIV/AIDS: prevalence, demographics, and risks. J. Adolesc. Health 25 (1999) 358-366
11. Des Jarlais D.C., Casriel C., Friedman S.R., and Rosenblum A. AIDS and the transition to illicit drug injection-results of a randomized trial prevention program. Br. J. Addict. 87 (1992) 493-498
12. Des Jarlais D.C., Perlis T., Friedman S.R., Chapman T., Kwok J., Rockwell R., Paone D., Milliken J., and Monterroso E. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. Am. J. Public Health 90 (2000) 1112-1116
13. Fennema J.S., van Ameijden E.J., van den Hoek J.A., and Coutinho R.A. The relative importance of young and recent-onset injection drug users in Amsterdam HIV epidemic 1986-1995. Int. Conf. AIDS 11 (1996) Mo.C.465
14. Fennema J.S., van Ameijden E.J., van den Hoek A., and Coutinho R.A. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction 92 (1997) 1457-1465
15. Fournier L., Chevalier S., Ostoj M., Caulet M., Courtemanche R., and Plante N. Dénombrement de la clientèle itinérante dans les centres d'hébergement, les soupes populaires et les centres de jour des villes de Montréal et Québec 1996-97. 2-Montréal: premiers résultats [Census of the homeless population in shelters, soup kitchens and day drop-in centres in the cities of Montreal and Quebec, 1996-1997. 2-Montreal: first results] (1998), Santé-Québec, Montréal, Canada
16. Gleghorn A.A., Marx R., Vittinghoff E., and Katz M.H. Association between drug use patterns and HIV risks among homeless, runaway, and street youth in Northern California. Drug Alcohol. Depend. 51 (1998) 219-227
17. Haley N., Roy E., Leclerc P., Boudreau J.-F., and Boivin J.-F. HIV risk profile of male street youth involved in survival sex. Sex. Transm. Infect. 80 (2004) 526-530
18. Hankins C., Alary M., Parent R., Blanchette C., Claessens C., and SurvUDI Working Group. Continuing HIV transmission among injection drug users in Eastern Central Canada: the SurvUDI Study, 1995 to 2000. J. Acquir. Immune Defic. Syndr. 30 (2002) 514-521
19. Hartgers C., van den Hoek A., Krijnen P., van Brussel G.H.A., and Coutinho R.A. Changes over time in heroin and cocaine use among injecting drug users in Amsterdam, The Netherlands, 1985-1989. Br. J. Addict. 86 (1991) 1091-1097
20. Hunt N., Stillwell G., Taylor C., and Griffiths P. Evaluation of a brief intervention to prevent initiation into injecting. Drugs: Educ. Prev. Policy 5 (1998) 185-194
21. Hunter G.M., Donoghoe M.C., Stimson G.V., Rhodes T., and Chalmers C.P. Changes in the injecting risk behavior of injecting drug users in London 1990-1993. AIDS 9 (1995) 493-501
22. Kipke M.D., Unger J.B., Palmer R.F., and Edgington R. Drug use, needle sharing, and HIV risk among injection drug-using street youth. Subst. Use Misuse 31 (1996) 1167-1187
23. Kral A.H., Lorvick J., and Edlin B.R. Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 24 (2000) 162-167
24. Kral A.H., Molnar B.E., Booth R.E., and Watters J.K. Prevalence of sexual risk behaviour and substance use among runaway and homeless adolescents in San Francisco, Denver and New York City. Int. J. STD AIDS 8 (1997) 109-117
25. Langendam M.W., van Brussel G.H.A., Coutinho R.A., and van Ameijden E.J.C. Trends in HIV risk behavior and methadone dosage among HIV-negative drug users: an ecological study. AIDS 14 (2000) 1870-1872
26. Longshore D., Jeffrey A., and Douglas A.M. Long-term trends in self-reported HIV risk behavior: injection drug users in Los Angeles, 1987 through 1995. J. Acquir. Immune Defic. Syndr. 18 (1998) 64-72
27. Montgomery S.B., Hyde J., De Rosa C.J., Rohrbach L.A., Ennett S., Harvey S.M., Clatts M., Iverson E., and Kipke M.D. Gender differences in HIV risk behaviors among young injectors and their social network members. Am. J. Drug Alcohol Abuse 28 (2002) 453-475
28. Mullen L., and Barry J. An analysis of 15-19-year-old first attenders at the Dublin Needle Exchange, 1990-97. Addiction 96 (2001) 251-258
29. National Institutes of Health Consensus Development Conference Statement (NIH CDCS). Management of hepatitis C. Natl. Inst. Health Consens. Statement 36 Suppl. 1 (2002, June 10-12) S3-S20
30. Novelli L.A., Sherman S.G., Havens J.R., Strathdee S.A., and Sapun M. Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users. Drug Alcohol Depend. 77 (2005) 303-309
31. Ochnio J.J., Patrick D., Ho M., Talling D.N., and Dobson S.R. Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs. Can. Med. Assoc. J. 165 (2001) 293-297
32. Parent, R., Alary, M., Morissette, C., Roy, É., Blanchette, C., Claessens, C., Clermont, P., Côté, A., Daigneault, J., Dubuc, S., Dumont, J., Gauthier, M., Leonard, L., Noël, L., Perreault, A., Rioux, L., Rochefort, J., 2006. Infectious diseases surveillance among injection drug users. Epidemiology of HIV from 1995 to 2004. Epidemiology of HCV from 2003 to 2004. SurvUDI I-Track study: report from the Institut national de santé publique du Québec. Québec, Canada.
33. Patrick D.M., Tyndall M.W., Cornelisse P.G., Li K., Sherlock C.H., Rekart M.L., Strathdee S.A., Currie S.L., Schechter M.T., and O'Shaughnessy M.V. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. Can. Med. Assoc. J. 165 (2001) 889-895
34. Peters A.D., Reid M.M., and Griffin S.G. Edinburgh drug users: are they injecting and sharing less?. AIDS 8 (1994) 521-528
35. Peters A., Davies T., and Richardson A. Increasing popularity of injection as the route of administration of amphetamine in Edinburgh. Drug Alcohol Depend. 48 (1997) 227-234
36. Pfeifer R.W., and Oliver J. A study of HIV seroprevalence in a group of homeless youth in Hollywood. California. J. Adolesc. Health 20 (1997) 339-342
37. Roy E., Haley N., Leclerc P., Cédras L., and Boivin J.-F. Hepatitis C among Montréal street youth cohort participants who injected drugs (MSYC-IDUs). Can. J. Infect. Dis. 12 Suppl. B (2001) 60B
38. Roy E., Haley N., Leclerc P., Cédras L., Blais L., and Boivin J.-F. Drug injection among street youths in Montréal: predictors of initiation. J. Urban Health 80 (2003) 92-105
39. Roy, É., Nonn, É., Haley, N., Morissette, C., 2003b. Le "partage" des matériels d'injection chez les jeunes usagers de drogues injectables de Montréal. Drogues, Santé et Société, p. 2. http://www.erudit.org/revue/dss/2003/v2/n1/007182ar.pdf.
40. Roy E., Haley N., Leclerc P., Sochanski B., Boudreau J.-F., and Boivin J.-F. Mortality in a cohort of street youth in Montréal. J. Am. Med. Assoc. 292 (2004) 569-574
41. Roy, É., Denis, V., Gutiérrez, N., Haley, N., Morissette, C., Boudreau, J.-F., 2006a. Evaluation of a media campaign aimed at preventing initiation into drug injection among street youth. Drugs: Educ. Prev. Policy, in press.
42. Roy, É., Alary, M., Morissette, C., Leclerc, P., Boudreau, J.-F., Parent, R., Rochefort, J., Claessens, C., The SurvUDI Working Group, 2006b. High HCV prevalence and incidence among Canadian IDUs. Int. J. STD AIDS, in press.
43. Roy E., Morissette C., Haley N., Gutiérrez N., and Rousseau L. Pourquoi commencer? L'initiation à l'Injection de drogues selon les jeunes de la rue. Drogues, santé et société 2 (2006) 45-75
44. Roy K., Hay G., Andragetti R., Taylor A., Goldberg D., and Wiessing L. Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature. Epidemiol. Infect. 129 (2002) 577-585
45. SAS Institute Inc., 2006. SAS (Version 9.1.3). SAS Institute Inc., Cary, NC.
46. Schottenfeld R.S., O'Malley S., Abdul-Salaam K., and O'Conner P.G. Decline in intravenous drug use among treatment-seeking opiate users. J. Subst. Abuse Treat. 10 (1993) 5-10
47. Smyth B.P., Barry J., and Keenan E. Syringe borrowing persists in Dublin despite harm reduction interventions. Addiction 96 (2001) 717-727
48. SPSS Inc., 2004. SPSS for Windows (Version 13.0). SPSS, New York, NY.
49. Stillwell G., Hunt N., Taylor C., and Griffiths P. The modelling of injecting behavior and initiation into injecting. Addict. Res. 7 (1999) 447-459
50. Strathdee S.A., Patrick D.M., Archibald C.P., Ofner M., Cornelisse P.G., Rekart M., Schechter M.T., and O'Shaughnessy M.V. Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addict. 92 (1997) 1339-1347
51. Strike C., Leonard L., Millson M., Anstice S., Berkeley N., and Medd E. Ontario Needle Exchange Programs: Best Practice Recommendations (2006), Ontario Needle Exchange Coordinating Committee, Toronto
52. Thorpe L.E., Bailey S.L., Huo D., Monterroso E.R., and Ouellet L.J. Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997-1999). J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 27 (2001) 71-78
53. Trang J., Griffiths P., Powis B., and Gossop M. First use of heroin: changes in route of administration over time. Br. Med. J. 304 (1992) 1222-1223
54. United Nations Programme on HIV/AIDS and World Health Organization (UNAIDS/WHO), 2005. AIDS epidemic update: special report on HIV prevention (accessed on June 10, 2006). Retrieved from http://www.unaids.org/epi/2005/doc/EPIupdate2005_pdf_fr/epi_update_2005_ fr.pdf.
55. van Ameijden E.J.C., and Coutinho R.A. Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS 12 (1998) 625-633
56. Vlahov D., Fuller C.M., Ompad D.C., Galea S., and Des Jarlais D.C. Updating the infection risk reduction hierarch: preventing transition into injection. J. Urban Health 81 (2004) 14-19
57. Welp E.A.E., Lodder A.C., Langendam M.W., Coutinho R.A., and van Ameijden E.J.C. HIV prevalence and risk behavior in young drug users in Amsterdam. AIDS 16 (2002) 1279-1284
58. World Health Organisation International Collaborative Group (WHO ICG), 1994. Multi-City Study on Drug Injecting and Risk of HIV Infection. World Health Organization, Program on Substance Abuse.
59. Zeger S.L., Liang K.-Y., and Albert P.S. Models for longitudinal data: a generalized estimating equation approach. Biometrics 44 (1988) 1049-1060